HuagongsheHuagongshe Chemistry Print Report · For research reference only
Potassium Iodide → 7-(2,4-Dichlorophenyl)-5-(ethylsulphanyl)-2-(morpholin-4-ylmethyl)imidazo[1,2-c]pyrimidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 2-(Chloromethyl)-7-(2,4-dichlorophenyl)-5-(ethylsulphanyl)imidazo[1,2-c]pyrimidine | HCID 59312998 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 7-(2,4-Dichlorophenyl)-5-(ethylsulphanyl)-2-(morpholin-4-ylmethyl)imidazo[1,2-c]pyrimidine | HCID 59313075 | — |
Reaction Steps
102 mg (1.17 mmol) of morpholine are introduced into 7 ml of DMF at 0° C., and 236 mg (0.78 mmol) of triethylamine and a catalytic amount of potassium iodide are added. A solution of 290 mg of 2-(chloromethyl)-7-(2,4-dichlorophenyl)-5-(ethylsulphanyl)imidazo[1,2-c]pyrimidine (Example 91A) in DMF is then slowly added dropwise. The mixture is allowed to reach RT and is stirred at this temperature for a further 16 h. Purification of the crude product by preparative HPLC and drying under high vacuum result in 214 mg (43% of theory) of product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08273752B2 |
| Source dataset | uspto-grants-2012_09 |
| ORD ID | ord-68240277c8be4acfac538fc8f966a241 |
| Source note | uspto-grants-2012_09 |